Research Roundup: A Potential End to Liver Transplants and MoreAllbiopro2019-08-03T23:19:57+09:008월 3rd, 2019|
Results Show Experimental RSV Vaccine Produces Increase in ProtectionAllbiopro2019-08-03T23:19:23+09:008월 3rd, 2019|
Amicus Therapeutics’ Gene Therapy for Rare, Fatal Childhood Disease Shows Promise in Early Clinical TrialAllbiopro2019-08-03T23:18:52+09:008월 3rd, 2019|
Is a Low-Cost Blood Test for Alzheimer’s on the Horizon?Allbiopro2019-08-03T23:18:17+09:008월 3rd, 2019|
Biopharma Q2 Reports: Sanofi, Pfizer, Charles River, Gilead and MerckAllbiopro2019-08-03T23:17:45+09:008월 3rd, 2019|
FiercePharmaAsia—Takeda’s cost-saving progress; Dr. Reddy’s shortfall; Strides’ China JVAllbiopro2019-08-03T23:17:15+09:008월 3rd, 2019|
Longtime pharma critic and Democratic candidate Sanders pledges importation action ‘on day one’Allbiopro2019-08-03T23:16:41+09:008월 3rd, 2019|
Could FTC scrutiny of the Roche-Spark merger scuttle future pharma deals? Analysts are frettingAllbiopro2019-08-03T23:16:11+09:008월 3rd, 2019|
The Sacklers strip-mined Purdue to avoid billions in settlements: Arizona AGAllbiopro2019-08-03T23:15:40+09:008월 3rd, 2019|
Fujifilm pays Biogen nearly $1B for Denmark biologics site Allbiopro2019-08-03T23:15:05+09:008월 3rd, 2019|
Clovis investors lose faith as Rubraca struggles against Big Pharma’s marketing giantsAllbiopro2019-08-03T23:14:36+09:008월 3rd, 2019|
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYTAllbiopro2019-08-03T23:14:03+09:008월 3rd, 2019|
Phase 3 trial of Transgene’s oncolytic virus halted for futilityAllbiopro2019-08-03T23:13:29+09:008월 3rd, 2019|
Could stem cell transplants make BMS’ checkpoint inhibitors work in resistant lymphoma?Allbiopro2019-08-03T23:12:58+09:008월 3rd, 2019|
Rakuten Medical reels in another megaround to fund cancer R&DAllbiopro2019-08-03T23:12:24+09:008월 3rd, 2019|
Chutes & Ladders—Mylan CEO Bresch to exit company after Upjohn mergerAllbiopro2019-08-03T23:11:51+09:008월 3rd, 2019|
